Study guide
HLA-B27, sarcoidosis, Behçet disease and VKH
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
HLA-B27, sarcoidosis, Behçet disease and VKH
Key Takeaways Explain This Topic AI
HLA-B27-associated attacks, granulomatous sarcoid patterns and posterior vascular disease have different systemic implications.
Behçet retinal vasculitis can threaten vision even when a single acuity measurement looks relatively good.
VKH assessment includes choroidal activity and systemic findings, with early coordinated control and monitoring of recurrence.
Last updated: October 2026
HLA-B27-Associated Anterior Uveitis
Human Leukocyte Antigen B27 (HLA-B27) is a major histocompatibility complex (MHC) class I surface glycoprotein encoded on chromosome 6. Approximately 50% of all acute non-granulomatous anterior uveitis presentations are HLA-B27 positive, making it the single most common endogenous uveitic syndrome in populations of European descent.
Clinical Phenotype and Presentation
Epidemiology: Typically presents in young adults (second to fourth decades), with a slight male preponderance among individuals with axial spondyloarthritis.
Ocular Hallmarks:
Acute, explosive onset: Rapid development of severe periocular pain, intense ciliary injection, marked photophobia, lacrimation, and blurred vision.
Unilateral and alternating: The inflammation affects usually one eye at a time , but frequently alternates to the contralateral eye during future recurrences. Simultaneous, bilateral acute onset is exceedingly rare ( < 2 % <2\% < 2% ) and should prompt immediate consideration of an alternative etiology (e.g., tubulointerstitial nephritis and uveitis [TINU] syndrome, sarcoidosis, or syphilis).
Heavy Fibrinous Exudate: Pronounced breakdown of the blood-aqueous barrier generates a dense, proteinaceous exudate within the anterior chamber, forming a thick fibrin coagulum across the pupil ( plastic aqueous ).
Hypopyon Formation: Present in 15% to 20% of severe attacks. Unlike the mobile hypopyon of Behçet disease, the HLA-B27 hypopyon is dense, sticky, gelatinous, and relatively fixed due to its high fibrin content.
Posterior Synechiae: High propensity for rapid formation of extensive 360-degree posterior synechiae, predisposing to iris bombé and acute pupillary block glaucoma.
Intraocular Pressure (IOP) Dynamics: IOP is characteristically subnormal initially due to severe ciliary body hyposecretion ("ciliary shock"). As inflammation resolves or if heavy fibrin clogs the trabecular meshwork, IOP may dramatically spike.
Systemic Spondyloarthropathies (SpA)
Approximately 50% of patients with HLA-B27 anterior uveitis have an underlying seronegative spondyloarthropathy:
Ankylosing Spondylitis (AS): The strongest association. Hallmarked by inflammatory back pain (worse at rest and early morning, improves with exercise, nocturnal waking), peripheral enthesitis (Achilles tendonitis, plantar fasciitis), progressive spinal rigidity, and bilateral sacroiliitis visible on pelvic radiography (New York criteria) or early bone marrow oedema on sacroiliac MRI.
Reactive Arthritis: Classically characterized by the clinical triad of urethritis/cervicitis, conjunctivitis/uveitis, and asymmetric oligoarthritis (predominantly involving weight-bearing joints of the lower extremities). Triggered by mucosal gastrointestinal ( Salmonella , Shigella , Campylobacter , Yersinia ) or genitourinary ( Chlamydia trachomatis ) infections. Mucocutaneous signs include circinate balanitis, keratoderma blennorrhagica, and painless oral aphthae.
Psoriatic Arthritis: Associated with cutaneous plaque psoriasis, nail dystrophies (pitting, oil-drop discoloration, onycholysis), and dactylitis ("sausage digits"). Uveitis may be insidious, bilateral, and chronic.
Inflammatory Bowel Disease (IBD): Associated with Crohn disease and Ulcerative Colitis. The activity of anterior uveitis frequently parallels peripheral articular arthritis flares rather than active gastrointestinal colitis flares.
Ocular Sarcoidosis
Sarcoidosis is a multisystem, idiopathic inflammatory disorder characterized pathologically by the formation of non-caseating epithelioid cell granulomas . Ocular involvement occurs in 25% to 50% of patients with systemic sarcoidosis and can affect every structure of the eye and ocular adnexa.
International Workshop on Ocular Sarcoidosis (IWOS) Diagnostic Criteria
The 2019 revised IWOS criteria use three categories after excluding other granulomatous causes:
Definite : Biopsy-supported sarcoidosis with compatible uveitis.
Presumed : No biopsy support, but bilateral hilar lymphadenopathy and at least two specified ocular signs.
Probable : No bilateral hilar lymphadenopathy or biopsy support, with at least three specified ocular signs and two qualifying systemic investigations.
The former possible category is not retained in the revised criteria.
Ocular Signs of Sarcoidosis (IWOS Consensus Signs)
Anterior Segment:
Large, greasy, waxy "mutton-fat" keratic precipitates and/or iris nodules (Koeppe nodules at pupillary border, Busacca nodules on iris stroma).
Trabecular meshwork nodules and/or tent-shaped peripheral anterior synechiae (PAS).
Intermediate and Posterior Segments:
Vitreous opacities presenting as inferior "snowballs" (cellular clumps) or linear aggregations resembling a "string of pearls".
Snowbanking over the inferior pars plana.
Multiple, discrete, punched-out peripheral chorioretinal lesions.
Retinal Periphlebitis: Segmental perivascular sheathing with nodular, yellowish-white exudates resembling candle-wax drippings ( "en taches de bougie" ).
Optic disc granuloma or solitary/multiple choroidal granulomas (yellow-white, subretinal, hypofluorescent on early and late indocyanine green angiography [ICGA]).
Bilateral ocular involvement (present in > 80 % >80\% > 80% of cases).
Diagnostic Investigations in Ocular Sarcoidosis
High-Resolution Chest CT (HRCT): Superior sensitivity to plain radiography for detecting symmetrical bilateral hilar lymphadenopathy (BHL) and subpleural micronodules.
Serum ACE & Lysozyme: Both enzymes are secreted by activated epithelioid macrophages within granulomas; elevated in 60% to 80% of active cases. ACE activity is falsely suppressed by ACE-inhibitor anti-hypertensives.
Tuberculin Skin Test (TST) / IGRA: Demonstrates cutaneous anergy (negative TST in > 80 % >80\% > 80% of sarcoidosis patients despite high population exposure) with a negative IGRA.
Bronchoalveolar Lavage (BAL): Elevated CD4 + : CD8 + \text{CD4}^+:\text{CD8}^+ CD4 + : CD8 + T-cell ratio > 3.5 >3.5 > 3.5 strongly supports pulmonary sarcoidosis.
Behçet Disease
Behçet disease is a systemic, recurrent, obliterative occlusive vasculitis affecting blood vessels of all sizes (arteries and veins) with a high prevalence along the ancient "Silk Road" (Eastern Mediterranean, Middle East, Central Asia, and Japan). It is strongly genetically linked to the HLA-B51 allele (MHC Class I).
Diagnostic Criteria (International Study Group [ISG] & ICBD)
The historical 1990 International Study Group (ISG) classification requires:
Mandatory Criterion: Recurrent oral aphthous ulcerations (observed by physician or reliably reported by patient ≥ 3 times \ge 3\text{ times} ≥ 3 times within a 12-month period).
Plus at least TWO of the following:
Recurrent Genital Ulcerations: Painful, discrete aphthous ulcers occurring on the scrotum, penis, or vulva; characteristically heal with cicatricial scarring.
Characteristic Eye Lesions: Anterior uveitis, posterior uveitis, retinal vasculitis, or cellular vitritis confirmed by an ophthalmologist.
Characteristic Skin Lesions: Erythema nodosum-like lesions, pseudofolliculitis, papulopustular eruptions, or acneiform nodules in post-adolescent patients not receiving corticosteroids.
Positive Pathergy Test: Formation of a sterile erythematous papule or pustule ( ≥ 2 mm \ge 2\text{ mm} ≥ 2 mm in diameter) 24 to 48 hours following oblique intracutaneous puncture of the forearm with a sterile 20-gauge needle.
Ocular Manifestations
The 2014 ICBD system differs: ocular lesions, oral aphthosis and genital aphthosis each score two points; skin, neurological and vascular manifestations each score one, with one additional point for a positive pathergy test when performed. A score of at least four meets the classification threshold. Oral ulceration is therefore not compulsory in that system. For example, genital aphthosis plus characteristic ocular disease totals four points without oral aphthosis. Classification supports research and clinical assessment; exclude mimics and judge the entire presentation rather than diagnosing from an isolated score. See the original international criteria study .
Ocular involvement develops in 60% to 80% of Behçet patients, typically 2 to 4 years following the onset of oral aphthae, and exhibits a significantly more aggressive and vision-threatening course in young males:
Bilateral Non-Granulomatous Panuveitis: Explosive, recurrent attacks characterized by intense intraocular inflammation.
The "Cold" Hypopyon: A characteristic, sometimes mobile, cellular, highly fluid and mobile hypopyon that shifts rapidly with head repositioning. It is termed "cold" because it can arise in an eye with deceptively minimal conjunctival or ciliary injection, and typically resolves spontaneously within several days.
Occlusive Retinal Vasculitis: Affects both retinal veins and retinal arteries ( diffuse obliterative arteriolitis and phlebitis ):
Retinal branch vein and artery occlusions.
Diffuse retinal capillary non-perfusion, severe ischaemia, cotton-wool spots, and flame haemorrhages.
Optic disc and retinal neovascularisation leading to non-clearing vitreous haemorrhage and tractional retinal detachment.
Recurrent uncontrolled vascular inflammation can cause irreversible ischaemic macular and optic-nerve damage; early coordinated treatment and surveillance are essential.
Vogt-Koyanagi-Harada (VKH) Disease
VKH disease is a severe, bilateral, granulomatous autoimmune panuveitis targeting melanocyte-associated antigens (including tyrosinase, tyrosinase-related proteins TRP-1 and TRP-2, and MART-1/Melan-A). It characteristically affects darkly pigmented individuals (Asians, Hispanics, Native Americans, and Middle Easterners) and is strongly associated with HLA-DR4 and HLA-DRB1*0405 .
The Four Clinical Phases of VKH
Clinical Phase Chronological Timing Key Pathophysiological and Clinical Hallmarks
1. Prodromal Phase Days to 1–2 weeks Systemic viral-like illness: severe diffuse headache, deep orbital pain, meningismus, scalp hyperaesthesia, vertigo, tinnitus, and sensorineural hearing loss. Lumbar puncture reveals cerebrospinal fluid (CSF) lymphocytic pleocytosis in > 80 % >80\% > 80% of patients with normal glucose.
2. Acute Uveitic Phase Weeks Profound, acute, bilateral vision loss. Diffuse granulomatous choroiditis producing marked, thickened choroid on B-scan and EDI-OCT. Multifocal serous neurosensory retinal detachments (clover-leaf appearance at the posterior pole), optic disc hyperaemia and oedema, and moderate vitritis.
3. Convalescent Phase Weeks to months Depigmentation of ocular and integumentary melanocytes. Fundus develops a bright orange-red appearance: "sunset-glow fundus" due to loss of choroidal melanin. Dalén-Fuchs nodules (sub-RPE granulomas). Sugiura sign (perilimbal vitiligo, characteristic in Japanese cohorts). Cutaneous signs: poliosis (whitening of eyelashes, eyebrows, hair), vitiligo , and alopecia .
4. Chronic Recurrent Phase Months to years Characterized by smouldering, recurrent bouts of anterior uveitis with mutton-fat KPs, iris stroma atrophy, Koeppe/Busacca nodules, cataract, glaucoma, subretinal fibrosis, and macular choroidal neovascular membranes (CNVM). Recurrent posterior pole serous detachments are rare in this phase.
Assess activity and prevent complications
In Behçet disease, recurrent occlusive retinal vasculitis requires activity assessment and systemic coordination; acuity alone can miss active peripheral disease. In VKH, choroidal activity and recurrence may require imaging even after serous fluid improves. Monitor pressure, cataract, macular oedema and steroid toxicity in both disorders. Immunomodulatory selection and monitoring are taught with posterior inflammatory patterns, and should follow the phenotype rather than a fixed escalation ladder for all patients.